News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials
Nico Gagelmann/X
Apr 13, 2024, 11:41

Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials

Nico Gagelmann, shared on their X/Twitter:

”Finally out. Methodological challenges in the development of endpoints for myelofibrosis clinical trials.”

Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials

Proceed to the article.
Source: Nico Gagelmann/X

cancer clinical research clinical trials drug development EBMT European Society for Blood and Marrow Transplantation Medical Research Methodological Challenges myelofibrosis Nico Gagelmann OncoDaily Oncology
Special Coverage
Science
May 3, 2025, 11:14
Myeloma Paper of the Day, May 3rd, suggested by Robert Orlowski
Blog
May 3, 2025, 10:35
Michael Baumann Honored with Jens Overgaard Legacy Award at ESTRO 2025
Blog
May 3, 2025, 10:19
Kristin Flanary Advocates for Conquer Cancer Day and Research Funding
Blog
May 3, 2025, 09:48
Robbie Beckert will present Award-Winning Research on Adaptive Radiotherapy at ESTRO 2025
Blog
May 3, 2025, 09:07
Miriam Mutebi: Cooking can serve as a therapeutic activity, promoting mental wellness and reducing stress
Blog
May 3, 2025, 09:06
Dirk Verellen Honored with Emmanuel van der Schueren Award at ESTRO 2025
Opinion
May 3, 2025, 08:36
SKAGEN Trial 1 at ESTRO 2025: Moderately Hypofractionated RT Safe, But Mortality Signal Warrants Caution
Blog
May 3, 2025, 08:03
Ruzanna Papyan: Julia Hoveyan on Access to Novel Therapies in the POEM Region at 4th POEM Scientific Meeting
Societies
May 3, 2025, 07:43
HYPO-RT-PC Phase III trial: Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up
Blog
May 3, 2025, 06:07
Icro Meattini: Challenges and Opportunities of Biomarker-Directed Optimisation of Breast Radiotherapy at ESTRO25
Blog
May 3, 2025, 06:03
Joint ESTRO-EORTC Session at ESTRO25
Insight
May 3, 2025, 05:42
FAST-Forward trial 10-year results from ESTRO 2025: Hypofractionated breast radiotherapy for 1 vs 3 weeks